AI biotechs Exscientia and Recursion agree to $688m merger

[cafead]

via In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 million.

article source